Fluid Biopsy Market to Observe Strong Development of 18.0% CAGR by 2023 – Analysis by Global Key Vendors - Bio-Rad Lab, Cynvenio, Diagnologix, Exosome Sciences, Grail, Illumina, Qiagen

Marketprognosis.com Publish a New Market Research Report On “Global Fluid Biopsy Market 2019 - 2023” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Fluid Biopsy Market:

The Global Fluid Biopsy Market is expected to register a CAGR of 18.0% during 2019 to 2023 (the forecast period).

Fluid biopsy, which is also known as liquid biopsy or fluid phase biopsy, is a procedure of sampling and analyzing nonu2013solid biological tissues (blood and others), for the screening of cancer and other inflammatory conditions, associated with cardiac and other medical disorders.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/16863 .

Cancer prevalence data indicates the number of people diagnosed with cancer in their lifetime. Prevalence is determined by how often a cancer occurs, and by how long people normally live after diagnosis. The key facts stated by WHO estimate that cancer is the second leading cause of mortality across the globe, with around 14 million new cases and 8.2 million cancer-related deaths in 2012, and 8.8 million deaths in 2015. The number of new cases is expected to rise by about 70% in the next two decades. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths, which can be attributed to the aging of the population. The future burden is expected to be even larger, because of the adoption of western lifestyles, such as smoking, poor diet, physical inactivity, and fewer childbirths, in economically developing countries. The demand for an early detection of the cancer is poised to influence the growth of the global market, in addition, rising demand of non-invasive procedures and lower cost with greater accuracy is expected to supplement the growth of this market.

Liquid biopsy, a technical revolution, has widely been used for the diagnosis of several common cancer types. However, the presence and development of alternative techniques might hamper the growth of the market. One such alternative technology that has been used in the recent times is the optical biopsy. It is a novel method that uses spectroscopy at selected wavelengths, to diagnose cancerous tumors or any pre-cancerous growths. Liquid biopsies mostly depend upon the tumor-derived cfDNA, for the identification of cancer. However, in some cases, these cfDNA have shown to account for less than 1% of the circulating DNA. In addition, normal genomic DNA is present in cfDNA that might create false positive results during the biopsy. As such, alternative methods with high sensitive techniques that can sequence even a small amount of mutant, tumor-derived cfDNA in context of high genomic DNA, is essential. With options, like optical biopsies and the effectiveness of tissue-derived biopsies, the growth of the liquid biopsy market may be hampered. The other factors, such as developing countries being keen on using traditional tissue-based biopsy techniques, are hindering market growth.

Purchase this report online with 105 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/16863 .

Asia-Pacific region has high market potential for the growth of the fluid biopsy market, due to high prevalence rate of cancer and increase in healthcare expenditure. This region is predicted to experience fast-paced growth, in terms of development and use of the fluid biopsy tests. North America has the highest market share and it is followed by the Europe.

Major Key Players:

1 Bio-Rad Laboratories

2 Cynvenio

3 Diagnologix

4 Exosome Sciences

5 Grail

6 Guardant Health

7 Horizon Discovery

8 Illumina

9 Qiagen

Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/16863 .

This study answers to the below key questions:

1 What will the market size be in 2023 and what will the growth rate be?

2 What are the key market trends?

3 What are the challenges to market growth?

4 Who are the key players in this market?

5 What are the market opportunities and threats faced by the key players?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Fluid Biopsy Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

sales@marketprognosis.com

+1 973 241 5193

https://www.marketprognosis.com

This release was published on openPR.